Hospice M&A rebounds but compliant assets in short supply – Dealspeak North America

Andrew Voss discusses the rebound in hospice M&A activity, noting that buyers are increasingly viewing hospice providers as part of a broader continuum of care rather than standalone businesses. He highlights that investors are prioritizing disciplined platform-building through strategic add-on acquisitions, while placing greater emphasis on compliance, operational stability and regulatory readiness than on growth alone. Voss also notes that heightened regulatory scrutiny and extended diligence processes have made high-quality, compliant hospice assets increasingly scarce, driving greater selectivity among buyers and influencing deal structures and valuations.